According to SNS Insider, the White Biotechnology Market size was valued at USD 276.7 billion in 2023 and is expected to reach USD 558.7 billion by 2032, growing at a CAGR of 8.1% over the forecast period of 2024–2032. The rapid advancements in industrial biotechnology, renewable bioenergy production, and sustainable raw material usage are key factors driving the market’s robust expansion.
White biotechnology—also known as industrial biotechnology—plays a transformative role in replacing traditional petrochemical processes with bio-based alternatives. It leverages enzymes, microorganisms, and renewable resources to produce industrially valuable products such as biofuels, enzymes, and biopolymers. With increasing global focus on sustainability and circular economy initiatives, white biotechnology is becoming an integral part of industrial transformation across the energy, agriculture, and pharmaceutical sectors.
The market growth is further supported by the increasing adoption of bio-based manufacturing, government incentives promoting renewable energy adoption, and technological innovation in fermentation and enzyme engineering. Strategic partnerships among leading biotechnology companies are also boosting production efficiency and expanding applications across multiple industries.
Get free Sample Report@ https://www.snsinsider.com/sample-request/1892
White Biotechnology Market Overview & Key Insights
The increasing urgency to combat climate change and reduce industrial emissions is steering global economies toward bio-based manufacturing. The Medical Isotope Market has seen parallel momentum in sustainable solutions, emphasizing eco-friendly technologies and advanced production systems. Similarly, white biotechnology applications are redefining value chains across agriculture, food, and pharmaceuticals by offering sustainable feedstock utilization and waste reduction.
Leading economies including the U.S., Germany, China, and India are heavily investing in the bioeconomy, with government policies fostering innovation and commercialization of advanced bio-based technologies. For instance, the U.S. Department of Energy (DOE) continues to fund research in biorefineries and sustainable biomass conversion, enhancing industrial competitiveness.
Segment Analysis
By Product
In 2023, the biofuels segment held the largest market share of around 38% in revenue. This dominance is primarily attributed to global efforts to promote renewable energy and minimize greenhouse gas emissions. According to the U.S. Energy Information Administration (EIA), biofuel production reached 17.5 billion gallons in 2023, reflecting a 5% increase from 2022.
Government policies such as the Renewable Fuel Standard (RFS) in the U.S. and the EU Renewable Energy Directive II (RED II), which mandates 14% renewable energy in the transport sector by 2030, are accelerating biofuel adoption. Additionally, the aviation industry’s shift toward sustainable aviation fuels under ICAO’s Carbon Offsetting and Reduction Scheme (CORSIA) is fueling further investment in white biotechnology for biofuel innovation.
By Application
The bioenergy segment accounted for 39% of the market share in 2023. The growing demand for renewable energy sources and carbon-neutral alternatives has reinforced bioenergy’s leadership. According to the International Energy Agency (IEA), modern bioenergy accounts for 50% of all renewable energy used globally and is projected to grow at 3% annually through 2025.
The pharmaceutical ingredients segment is expected to witness the fastest growth due to increased demand for bio-based drug production. In 2023, 25% of the 53 new FDA-approved drugs were manufactured using biotechnology-based methods. The rise in personalized medicine, environmental sustainability goals, and the cost efficiency of biotechnological processes are further driving adoption in pharmaceutical applications.
Regional Analysis
North America
North America dominated the White Biotechnology Market in 2023, capturing a 35% share, owing to its robust R&D infrastructure, advanced bio-manufacturing capabilities, and favorable regulatory support. According to the U.S. Department of Agriculture (USDA), bio-based products generated USD 470 billion in economic value and supported 4.6 million jobs across the U.S. in 2023.
Asia-Pacific
The Asia-Pacific region is projected to register the fastest CAGR through 2032, driven by expanding industrialization, environmental policies, and large-scale government investments. China’s 14th Five-Year Plan (2021–2025) designates biotechnology as a strategic industry, while India’s National Biotechnology Development Strategy (2021–2025) has allocated USD 3.5 billion toward developing sustainable bio-based technologies. Growing populations and expanding bioeconomies are expected to further elevate the region’s market presence.
Key Companies Profiled
Novozymes A/S
BASF SE
DowDuPont Inc.
DSM N.V.
Evonik Industries AG
Cargill, Incorporated
Lonza Group Ltd.
Amyris, Inc.
Archer Daniels Midland Company (ADM)
Global Bioenergies SA
White Biotechnology Market Report Scope
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | USD 276.7 Billion |
| Market Size by 2032 | USD 558.7 Billion |
| CAGR (2024–2032) | 8.1% |
| Base Year | 2023 |
| Forecast Period | 2024–2032 |
| Historical Data | 2020–2022 |
| Segments Covered | Product, Application, Region |
| Regions Analyzed | North America, Europe, Asia-Pacific, Latin America, Middle East & Africa |
FAQs
1. What is white biotechnology?
White biotechnology, also called industrial biotechnology, involves using microorganisms and enzymes to produce chemicals, materials, and fuels in an eco-friendly manner.
2. What are the main drivers of the White Biotechnology Market?
The market is driven by sustainability initiatives, technological innovation in enzyme engineering, and increasing government incentives for bio-based production.
3. Which region dominates the global White Biotechnology Market?
North America holds the largest market share, while Asia-Pacific is projected to record the highest growth rate during the forecast period.
4. How does white biotechnology benefit pharmaceutical manufacturing?
It provides cleaner, more efficient, and sustainable production routes for drug synthesis, improving purity and reducing manufacturing costs.
5. Who are the leading companies in the market?
Major players include BASF SE, Novozymes A/S, DuPont, DSM, Evonik Industries, and ADM.
Other Trending Reports
Healthcare Predictive Analytics Market
